OBJECTIVE: To investigate whether leptin interferes directly with glycogenolysis and gluconeogenesis in isolated rat hepatocytes and also in in situ rat perfused livers. ANIMALS: Male albino rats (200 ± 250 g) were used in all experiments. MEASUREMENTS: D-glucose, L-lactate and pyruvate production. RESULTS: In the present study, no differences were found for the rates of glycolysis, as expressed by the areas under the curves, among control (24.2AE AE5.0 mmola ag), leptin (32.0AE AE4.5 mmola ag), glucagon (24.7AE AE3.0 mmola ag), and the leptin glucagon (23.8AE AE3.4 mmola ag) groups. No difference was found for the rates of glycogenolysis between the control and the leptin perfused livers (15.2AE AE3.9 and 15.0AE AE3.2 mmola ag, respectively). In the presence of glucagon, the areas under the curves for the rate of glycogenolysis rose to 108.6AE AE3.8 mmola ag. When leptin was combined with glucagon, the area under the curve for glycogenolysis was 43.7AE AE4.3 mmola ag. In fact, leptin caused a reduction of almost 60% (P`0.001) in the rate of glucagon-stimulated glycogenolysis. Under basal conditions, the addition of leptin (100 nga aml) to the incubation medium did not elicit any alteration in glucose production by isolated hepatocytes. However, in the presence of leptin, the production of glucose from glycerol (2 mM), L-lactate (2 mM). L-alanine (5 mM) and L-glutamine (5 mM) by the isolated hepatocytes was signi®cantly reduced (30%, 30%, 23% and 25%, respectively). The rate of glucose production (glycogenolysis) by isolated hepatocytes was not different between the control and the leptin incubated groups (445.0AE AE91.0 and 428.0AE AE72.0 nmola a10 6 cellsa ah, respectively). CONCLUSION: We conclude that leptin per se does not directly affect either liver glycolysis or its glucose production, but a physiological leptin concentration is capable of acutely inducing a direct marked reduction on the rate of glucagon-stimulated glucose production in in situ rat perfused liver. Leptin is also capable of reducing glucose production from different gluconeogenic precursors in isolated hepatocytes.
Introduction
The discovery of the ob gene, 1 and also the properties of its product, leptin, have shed new light on the regulation of body weight and energy metabolism. Obesity has been largely related to insulin resistance, and the treatment of obaob mice 2 ± 4 with leptin injections has promoted marked reductions in body weight, glycaemia, and insulinaemia. Pair-feeding studies 5 and experimental hyperleptinaemic animal models 6 provide evidence that leptin exerts adipose-reducing effects in excess of those induced by decreases in food intake, suggesting a signi®cant metabolic regulation role for leptin, in addition to appetite suppression. Additionally, it has been reported that OB-R receptors, known to be expressed in the hypothalamus, are also present in peripheral tissues such as adipocytes, skeletal muscle and liver. 7, 8 Based on these ®ndings it has been hypothesized that leptin may interfere with glucose metabolism by acting directly on peripheral tissues. In fact, it has been reported that leptin exerts a direct effect on glucose metabolism in skeletal muscle 9 and also in isolated adipocytes. 10 In vitro studies with human hepatic cell lines (HepG2, HepG3) and the rat hepatoma cell line H4-II-E 11 have reported that leptin causes attenuation of several insulin-induced effects. Contrary ®ndings have also been provided with rat (H-35) and human (HepG2) hepatoma cell lines expressing the long form of the leptin receptor (OB-R L ). 12 The presence of leptin did not cause any signi®cant alteration in insulin effects on these hepatoma cells, 12 therefore not contributing to the diabetic symptoms associated with obesity.
In vivo (euglycaemic hyper-insulinaemic clamp) studies 13 have demonstrated that an acute increase in plasma leptin enhances the inhibitory effect of insulin on hepatic glucose production, and induces a redistribution of intra-hepatic glucose¯uxes and changes in the gene expression of hepatic enzymes that closely resemble those of fasting.
The in vitro 11, 12 (carried out with hepatic cell lines) and in vivo 13 (euglycaemic hyper-insulinaemic clamp) studies have focused on the effects of leptin on insulin actions and hepatic glucose production, and have generated con¯icting results regarding the role of leptin in liver glucose metabolism. To add more to the discussion, it has recently been reported that in the presence of leptin, adrenaline-stimulated hepatic glucose release is suppressed by 48% in perfused livers. 14 These perfusion studies of isolated rat liver strongly indicate that leptin directly and acutely modulates hepatic glucose¯uxes.
To delineate whether leptin acutely and directly interferes with liver glucose metabolism, we performed liver perfusion and incubation of isolated hepatocytes in the presence and absence of leptin. Glucose release, glucagon-stimulated glucose release, glycolysis, and the production of glucose in the presence of gluconeogenic precursors (glycerol, Llactate, L-alanine and L-glutamine) were evaluated.
Methods

Animals
Male albino rats (Wistar strain, 200 ± 250 g) were maintained on a 12 ± 12 h light ± dark cycle at 22 C. The animals used to study gluconeogenesis in isolated hepatocytes were not allowed to eat for 24 h before the experiment, and the ones used for glycogenolysis received food (Nuvital 1 commercial chow) and water ad libitum. For the perfusion experiments, the animals were assigned to four groups: control (liver perfusion with Krebs Henseleit buffer, KHB), leptin (10 ngaml), glucagon (1 nmolal), and leptin (10 ngaplus; glucagon (1 nmolal). The average blood glucose was 4.61 AE 0.71 mmolal and 7.72AE 0.60 mmolal for the fasted and ad libitum fed animals, respectively. Ethics approval was granted for the study by the Institute of Biomedical Sciences, Animal Experimental Committee, University of Sa Äo Paulo.
Chemicals
Recombinant leptin (r-MuLeptin, purity b 95%, pure by SDS ± PAGE, 1 mgaml, formulation Ð phosphate buffered saline, pH 6.7, sterile ®ltered) was supplied by AMGEN Inc. (Thousand Oaks, CA). Leptin was kept in a deep freezer ( 7 70 C) and thawed immediately before the experiments. Glucagon (1 mg) was obtained from Eli Lylli do Brazil Ltda.
In Situ liver perfusion
Haemoglobin-free, monovascular, anterograde liver perfusion was performed. 15 Brie¯y, the animals were anaesthetized with pentobarbital sodium (35 mgakg) and were submitted to laparotomy. Afterwards, blood was collected from the inferior cava vein for determination of glycaemia. The livers were perfused in situ using Krebs ± Henseleit bicarbonate buffer (KHB), pH 7.4, saturated with an oxygenacarbon dioxide mixture (95a5%). The perfusion¯uid was pumped through a temperature regulated (37 C) membrane oxygenator prior to entering the liver via a cannula inserted into the portal vein. The perfusion was performed in an open system, without recirculation of the perfusate. A constant¯ow rate in each individual experiment was adjusted according to the liver weight (4 mlag of tissue fresh weightamin), considering that the liver weight of an ad libitum fed animal corresponds to 4% of its body weight. At the end of the perfusion, livers were extracted and weighed for precise metabolic calculations and correction of¯ow rates. Leptin (10 ngaml) andaor glucagon (1 nmolal) were added to the perfusion medium between the 20th and 30th minute of perfusion. Livers kept homogenous form and brown colour throughout the experiment, indicating suf®cient vascular perfusion and viability. 16 During the liver perfusion time (50 min), samples of the perfusate were collected every 2 min and used for the determination of D-glucose, L-lactate and pyruvate.
Isolation of hepatocytes
Isolation of hepatocytes was performed as previously described. 17 Brie¯y, the animals were anaesthetized with pentobarbital sodium (35 mgakg), submitted to laparotomy and blood was collected from the inferior cava vein for determination of glycaemia. Initially haemoglobin-free, monovascular, anterograde liver perfusion was performed 15, 18 for 20 min with a calcium-free Krebs ± Henseleit buffer containing 10 mM glucose. In order to¯ush all the blood from the organ, the ®rst 50 ml of perfusate was allowed to pass through the liver directly to waste. Afterwards, collagenase (0.05%) and calcium (2.5 mM) were added to the perfusion medium. All the media utilized for perfusion were gassed with a mixture comprising 95% O 2 and 5% CO 2 and the temperature was held at 37 C. Perfusion with collagenase was performed at a rate of 50 ± 60 mlamin and the perfusate was returned to the reservoir and recirculated. After 5 ± 10 min,¯uid started to ooze freely from the surface of the liver. Within 10 ± 30 min loss of¯uid from the liver surface was too great for the perfusion to be maintained. At this point the consistency of the liver was so soft that it disintegrated on pressure unless handled very gently. The liver was then carefully removed, transferred to a petri dish with 10 ± 20 ml of enzyme medium at 4 C, and broken up with a blunt spatula. After ®ltration and centrifugation, we obtained a supernatant with 95 ± 98% isolated hepatocytes that, upon microscopic examination, did not stain with tryphan blue.
Incubation of isolated hepatocytes
For gluconeogenesis studies, ®ve groups of isolated hepatocytes (2 Â 10 6 cellsaml) Ð glycerol (2 mM), Llactate (2 mK), L-alanine (5 mM), L-glutamine (5 mM), and basal (no substrate) Ð were incubated with KHB for 60 min in the presence or absence of leptin (100 ngaml). For glycogenolysis studies, two groups were assigned (2 Â 10 6 cellsaml), KHB (control) and KHB leptin (100 ngaml), and also incubated for 60 min. All¯asks were gassed (O 2 aCO 2 , 95a5%) during the entire incubation period and maintained in a shaking water bath t 37 C. Immediately after the 60 min incubation period, trichloroacetic acid (TCA) was added to the¯asks; the incubation medium was then centrifuged and the supernatant was used for glucose determination.
Analytical procedures
D-glucose, L-lactate and pyruvate were determined as previously described. 7 Glycogenolysis represents the sum of D-glucose and half of L-lactate and pyruvate values (D-glucose 1 2 ( L-lactate pyruvate)). Glycolysis represents the sum of L-lactate and pyruvate values. 7 All metabolic calculations were referred to the wet weight of the liver. The glucose oxidase method was used to measure glucose in the incubation medium. 19 
Statistical analysis
With the help of Instat software, ANOVA with Tukey ± Kramer and multiple comparison test and Student's t-test were performed to assess the signi®-cance of effects of leptin on the various parameters measured during liver perfusion and hepatocyte incubation. The areas under the curves (AUCs) were calculated with the help of Prism software. Data are expressed as the mean AE s.e.m. P`0.05 was the accepted level of signi®cance.
Results
In the present study, no signi®cant differences were found for the rates of glycolysis, as expressed by the areas under the curves (AUCs), among control (24.2 AE 5.0 mmolag), leptin (32.0 AE mmolag), glucagon (24.7 AE 3.0 mmolag), and the leptin glucgon (23.8 AE 3.4 mmolag) groups (Figure 1) . No difference was found in the AUC for the rates of glucose production between the control and the leptin perfused livers (15.2 AE 3.9 and 15.0 AE 3.2 mmolag, respectively). In the presence of glucagon, the AUC for the rate of glucose production rose to 108.6AE 3.8 mmolag. When leptin was combined with glucagon, the rate of glucose production by the perfused liver (as expressed by the AUC) was 43.7AE 4.3 mmolag (Figure 2 ). This indicates that leptin per se does not affect liver glucose production, but is capable of inhibiting the effect of glucagon on this variable. In fact, leptin caused a reduction of almost 60% (P`0.001) in the rate of glucagonstimulated liver glucose production ( Figure 2) .
Under basal conditions (without any of the gluconeogenic substrates), the addition of leptin (100 ngaml) to the incubation medium did not elicit any alteration in glucose production by hepatocytes isolated either from fasted ( Figure 3 ) or from ad (Table 1) . However, in the presence of several gluconeogenic precursors (glycerol, L-lactate, L-alanine and L-glutamine), the production of glucose by the incubated hepatocytes was signi®cantly reduced (30%, 30%, 23% and 25%, respectively) when leptin was added to the incubation medium ( Figure 3) . These results suggest that leptin per se exerts an acute inhibitory effect on gluconeogenesis in isolated hepatocytes.
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Discussion
Recent in vivo euglycaemic hyperinsulinaemic clamp studies 13 have reported that leptin (administered intravenously for 6 h) enhances insulin's ability to inhibit hepatic glucose production, and induces redistribution of intra-hepatic glucose¯uxes with a marked suppression of hepatic glucose production due to inhibition of glycogenolysis. With our in vitro liver perfusion studies we observed that leptin by itself is not capable of altering glucose production by the liver, but that it markedly reduces the rate of glucagon-stimulted heptic glucose production. It is important to notice that, even under two different conditions (in vivo euglycaemic hyperinsulinaemic clamp and in situ liver perfusion), the presence of leptin has been associated with a reduction of hepatic glycogenolysis. On the other hand, our demonstration that leptin reduces glucose production by isolated hepatocytes in the prescence of gluconeogenic precursors (glycerol, L-lactate, L-alanine, and L-glutamine) does not appear to be in agreement with an increase in PEPCK (phosphoenolpyruvate carboxykinase) gene expression as reported either in vivo 13 or in vitro. 11 These previous studies pointed out an increase in PEPCK gene expression either after 6 h of intravenous leptin infusion in rats 13 or after the incubation of hepatoma H4-II-E cells for 2 h in the presence of supra-physiological leptin concentrations ( $ 960 ngaml). 11 These ®ndings seem contradictory to our results (average reduction of 27% in glucose production from different gluconeogenic substrates). However, in our experiments, we used isolated rat hepatocytes instead of cell lines, and exposed them to a much lower leptin concentration (100 ngaml) and also for a shorter period of time (1 h). It is important to point out that 
(n 4).
Acute effects of leptin RB Ceddia et al within this 1 h incubation period no signi®cant alterations may have occurred in expression of gluconeogenic enzymes, therefore the reduction in glucose production in the presence of gluconeogenic substrates observed in our experiments seems to be due to a mechanism independent of gene expression. In addition, previous in vivo experiments 13 were carried out under adverse physiological conditions in the presence of high insulin concentrations (euglycaemichyperinsulinaemic clamp), which could also account for the difference reported here.
It has been reported that in hepatocytes freshly isolated from ad libitum fed rats there is a rise in the rates of glycolysis and glycogenolysis due to an increase in AMP levels, a condition resembling cells under hypoxia. 20 AMP is known to act as an allosteric activator of phosphofructokinase and glyocogen phosphorylase. Based on this, it could be argued that the inhibition of amino acid-stimulated gluconeogenesis (and also other precursors) caused by leptin was due to hypoxia leading to intensive glycolysis followed by an increase in lactate production. This condition could provoke an alteration of the capability of the hepatocytes to respond to gluconeogenic precursors. This does not seem to be the case here, ®rstly because we used 24 h fasted rats for the experiments on gluconeogenesis in contrast to previous studies 20 where ad libitum rats were used for the isolation of hepatocytes. Furthermore, compared to the control group (no substrate), we have observed that in the presence of gluconeogenic precursors the average glucose production from all groups of incubated hepatocytes increased 4-fold and 3.5-fold in the absence and presence of leptin, respectively. This indicates that the gluconeogenic response of these incubated heptocytes was well preserved during the course of the experiment. Provided that the incubation conditions were the same for all groups, we can conclude that leptin is altering the metabolic¯ux in these hepatocytes. The reduction of glucose production from glycerol could suggest sites for leptin action upstream of the triose phosphate stage. Glucose-6 phosphatase could be down-regulated in parallel with up-regulation of he glycogen synthase pathway, which would explain the reduction in hepatocyte release of newly synthesized glucose molecules from the gluconeogenic precursors added to the incubation medium. In fact, it has been recently reported that leptin (4.0 ± 5.0 ngaml) administered directly to obaob perfused liver in vitro, caused an increase of approximately 60% of glycogen synthesis as compared with untreated control obaob liver. 21 Leptin treatment in vitro also markedly enhanced glycogen synthesis (100%) in liver from normal lean mice. These in vitro data are supported by leptin treatment of obaob mice in vivo that caused a 3-fold increase in the activity of the a-form of the hepatic glycogen synthase. 21 The ®nding of enhanced hepatic glycogen synthesis after short-term leptin treatment is consistent with leptin modulating pathways that control hepatic glycogen synthesis in an insulinindependent manner.
Since we have not measured glycogen synthesis in our experiments, it is also important to consider that under fasting conditions and also in the absence of other exogenous substrates, glycerol, lactate, glutamine and alanine added to the incubation medium could have been oxidized in order to generate energy for the maintenance of hepatocyte metabolism. An increase in the rate of hepatocyte oxidation could be responsible for reducing the release of new synthesized glucose molecules in the incubation medium. Previous data from our laboratory have demonstrated that leptin is capable of stimulating glucose decarboxylation in isolated soleus muscle 9 and also in cultivated adipocytes. 10 Leptin per se did not cause any direct effect on glycogenolysis either in isolated hepatocytes or in perfused livers. However, leptin caused a signi®cant reduction in glucagon-stimulated glycogenolysis in perfused livers extracted from ad libitum fed animals. The mechanism by which leptin inhibits glucagonstimulated glycogenolysis in liver remains to be determined. However, reverse transcriptase ± polymerase chain reaction and mRNA protection analyses 7, 8 have revealed that various peripheral organs, including the liver, have detectable levels of mRNA encoding both the long (OB-R L ) and the short (OB-R s ) forms of the leptin receptor. The abundance in peripheral tissues of the long isoform expressed as a percentage of the total Ob-R mRNA ranges from 2 to 11%, reaching 5% in the liver. 8 Through its OB-R L receptors in hepatocytes, leptin may have exerted the inhibitory effect on gluconeogenesis in isolated hepatocytes and on glucagon-stimulated glycogenolysis in perfused livers found in the present study.
In vitro studies with hepatic cell lines have reported that leptin attenuates several insulin-induced activities, 11 probably by altering the insulin intracellular signalling pathway. The exposure of human hepatic cell lines to leptin reduced tyrosine phosphorylation of the insulin receptor substrate-1 (IRS-1) and association of the adapter molecule growth factor receptorbound protein 2 with IRS-1. In contrast, leptin increased the activity of IRS-1-associated hosphatidylinositol 3-kinase. 11 It has recently been reported that in in vitro perfused livers the incremental adrenalinestimulated hepatic glucose release is suppressed in the presence of either leptin or insulin and no further inhibition is observed when both hormones are combined.
14 Based on these data the authors speculated that leptin could be exerting such an inhibitory effect on noradrenoline-stimulated liver glucose release signalling via the same intracellular pathway as that of insulin. Our ®ndings that leptin per se does not alter either glycolysis or the rate of glucose release in perfused livers indicate that these previously reported intracellular steps of insulin signalling may not be involved in the inhibition of glucagon-stimulated glycogenolysis. It is also reinforced by in vivo observations that leptin enhances the insulin inhibition of hepatic glucose production, suggesting different Acute effects of leptin RB Ceddia et al signalling pathways for these two hormones. It is important to notice that glucagon receptors are coupled to G proteins and adenylate cyclase and cAMP production. This intracellular signalling pathway is clearly different from that of insulin, therefore the inhibitory effect of leptin on glucagon-stimulated glycogenolysis in hepatocytes reported by us must be due to an unde®ned mechanism that awaits further investigation. We can also speculate that leptin is interfering with glucagon binding to its receptors in hepatocytes, and therefore reducing the cell response to the hormone. Previous published data have demonstrated that leptin inhibits insulin binding to its receptors in isolated adipocytes. 22 Binding of glucagon in hepatocytes is another possibility that deserves future investigation.
In non-obese humans, plasma leptin values lie between 1 and 20 ngaml, while values up to 100 ngaml can be found in obese patients. 6 The leptin concentrations (10 and 100 ngaml) applied in our experiments are within this physiological range. It indicates that, at least in liver, supra-physiological leptin concentration are not necessary to trigger its direct effects on glucose metabolism.
Future studies are needed to identify the mechanism(s) by which leptin acts acutely and directly on liver cells altering glucose¯uxes. Also, it is necessary to clarify how leptin interacts with other hormones to regulate heptic glucose metabolism in obese subjects with type 2 diabetes. We conclude that leptin per se regulates glucose metabolism in isolated hepatocytes, and is also capable of inducing a direct and acute reduction on glucagon-stimulated glucose production in in situ rat perfused livers.
